Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Volpara Health Technologies.
RELATED STOCKHEAD STORIES
Health & Biotech
Breast cancer play Volpara delivers full-year bumper revenue, share price up 5pc
News
Market highlights and 5 ASX small caps to watch on Thursday
Experts
ScoPo’s Powerplays: A disappointing week for healthcare investors
News
Market highlights and 5 ASX small caps to watch on Thursday
News
Market highlights and 4 ASX small caps to watch on Tuesday
Experts
ScoPo’s Powerplays: Be cautious in May, but check out Volpara
Health & Biotech
Imugene gains 10pc on cancer vaccine progress; 3 other biotechs getting patents
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
News
Last Orders: Small caps snap three-day winning streak
Health & Biotech
Volpara shares gain on $23m acquisition of breast-cancer risk assessment company
Experts
ScoPo’s powerplays: Market hit by profit-taking, but healthcare outperforms
News
Last Orders: What you might have missed on the ASX today
Guides
Brainchip leads the ASX’s top small cap AI stocks in 2020
Health & Biotech
Volpara Health shares dip as losses, revenue grows
News
Last Orders: What you might have missed on the ASX today
Experts
ScoPo’s health powerplays: ‘We said October was going to be volatile’
Experts
